Welcome to the HIV/AIDS Prevention Research Division

The mission of the HIV/AIDS Prevention Research Division is to develop and evaluate interventions designed to reduce the spread of HIV and other blood-borne infections. The division promotes the application of evidence-based practices in the development of public health policies to respond to the HIV epidemic.



Clinical trial to test immune modulation strategy for hospitalized covid-19 patients begins


Part of NIH’s STRIVE consortium, the therapeutic may prevent overactive immune systems from causing severe symptoms.

Researchers develop new method to identify potential stroke therapies


First-of-its-kind study points to uric acid as a promising treatment for further investigation.

Researchers discover biomarker for tracking depression recovery


New deep brain stimulation device coupled with powerful AI may improve therapy for treatment-resistant depression.

Clinical trial of HIV vaccine begins in United States and South Africa


Novel vaccine includes NIH-funded technology in development since 2004.

Higher buprenorphine doses associated with improved retention in treatment for opioid use disorder


NIH-funded study suggests need to reevaluate opioid addiction treatment recommendations in the era of fentanyl.